CAT and metabolic dysfunction-associated steatotic liver disease: Cheng et al. demonstrated that miR-421 overexpression significantly decreased hepatic MnSOD and CAT expression and subsequently aggravated oxidative damage upon NAFLD stimulation via directly targeting sirtuin 3 [53].